Upon entry into the mammary gland, mammary pathogenic strains of Escherichia 31 coli rapidly grow using milk as a nutrient source, in a manner highly dependent on the 32 expression of the ferric-dicitrate system by these bacteria. Intra-mammary challenge with 33 distinct mammary pathogenic E. coli (MPEC) strains result in development of clinical 34 acute mastitis, with peak bacterial counts in milk at 16-24 h post-challenged and profound 35 immune changes found in the milk. The main biochemical changes measured in milk 36 were partially in accord with lipopolysaccharide-induced mastitis, with increased 37 glucose-6-phosphate and lactate dehydrogenase activity or prolonged lactate 38 dehydrogenase, and Glu6P/Glu alterations. Changes also reflect physiological responses 39 to inflammation in the mammary gland, as in the balance between aerobic and anaerobic 40 metabolism (citrate to lactate ratios). Some alterations measured in milk resolved with 41 days after challenge but other remained for above one month, regardless of bacterial 42 clearance. The results suggest that E. coli mastitits can be divided into two stages: an 43 acute, clinical phase, as an immediate response to bacterial infection in the mammary 44 gland and a chronic phase, independent of bacteria clearance, and in response to the tissue 45 damage caused in the first phase. 46 47
Introduction 51
Escherichia coli is the main pathogen causing acute mastitis in cattle, a disease of 52 significant economic and animal welfare impact in dairy production worldwide. Upon 53 entry into the mammary gland, mammary pathogenic strains of E. coli rapidly grow using 54 milk as a nutrient source, in a manner highly dependent on the expression of the ferric- 55 dicitrate system by these bacteria [1] [2] [3] . The resulting infection leads to an acute 56 inflammation that causes a sharp decrease in milk yield and deep changes of milk 57 properties and constituents [4] . Even after clinical healing and infection clearance in the 58 mammary gland indicated by cessation of bacterial secretion in the milk, milk yield and 59 quality might remain impaired for a long period in a significant number of affected cows. 60 The degree and length of the post-acute inflammation effect on udder health and milk 61 quality vary greatly and may depend on the health status of the individual animal, time of 62 diagnosis and treatment, as well as the infecting E. coli strain [5] . 63 Recently, intra-mammary challenge with distinct mammary pathogenic E. coli 64 (MPEC) strains (VL2874, VL2732 and P4) and with the non-mammary pathogenic E. 65 coli strain K1, was conducted in order to study if the dynamics and intensity of the 66 immune response in bovine mammary glands is different, depending on E. coli strains 67 [4] . Cellular and chemokine responses and bacterial culture follow-up were performed 68 for 35 days post-challenge. Cows challenged by any of the MPEC strains developed 69 clinical acute mastitis with peak bacterial counts in milk at 16-24 h post-challenge. During 70 the 35 days of the study, differences were found in the intensity and duration of the 71 response in various of the parameters studied, namely the somatic cells count (SCC), 4 72 leukocytes distribution, secreted cytokines (TNF-α, IL-6 and IL-17) and levels of 73 membrane TLR4 on leukocytes in milk. 74 Although a lot has been studied about the immune and inflammatory reaction to E. 75 coli in the mammary gland, less is known about the physiological and biochemical 76 changes that occur in the gland and in the milk during and following intra-mammary 77 infections by these bacteria. In a previous study [6] , it was shown that under acute 78 mammary inflammation induced by intra-mammary challenge of cows with E. coli 79 lipopolysaccharide (LPS), the passage of glucose-derived carbons shifts to the pentose 80 phosphate pathway, leading to a cell metabolism shift to glycolysis at the expense of 81 mitochondrial respiratory activity. A negative correlation between milk secretion and 82 lactose, glucose and citrate concentrations and inflammation parameters was described. 83 In parallel, the concentrations of glucose- Three different E. coli strains were used for the intra-mammary challenge: VL2874 117 (isolated from per-acute mastitis), VL2732 (isolated from persistent mastitis) and P4 118 (widely used as model strain for mammary pathogenic E coli). Strains typing, phenotypic 119 and genomic characteristics were described before [2, 7, 8] . Bacteria were recovered from 120 frozen stock (kept at -80 ºC in a mixture of brain-heart infusion and 25% glycerol) on (gain in milk yield) was recorded. Overall, cow's milk yield decreased by 10-30% at the 235 end of the study (Fig. 2) . The loss of milk yield per average cow during the 35 days of 236 the study was 336 L (32%). Milk yield of infected glands significantly correlated with 237 most of the parameters tested and significantly negatively correlated with SCC at the cow 238 level (S1 Fig.) .
240
Biochemical response to E. coli challenge 241 No significant results were found between the distinct MPEC strains; therefore, the 242 following results are presented for the three MPEC strains combined. 243 The statistical significance (P values) of the ANOVA results for the Day effect, R 2 244 and % variance between cows from the overall variance in the trial is summarized in 245 Table 1 . Fat in milk decreased during the first 2 h and then significantly increased 246 (P<0.001) up to 7-10 DPC and gradually returned to pre-challenged level only at 35 DPC 247 ( Fig. 3) . A significant decrease (P<0.001) in total protein was already noticed in 6-8 h 12 248 DPC, after which total protein levels in milk increased up to a peak at 7-10 DPC and 249 remained high till the end of the study, returning to pre-challenged levels at 35 DPC. In 250 parallel, % casein decreased significantly from ~78% to ~68% between 8-24 h post-251 challenge, then gradually increased afterwards but remained significantly lower than pre-252 challenged levels until the end of the study (35d) (Fig. 3, Y2 ). the others (Fig. 5) . The kinetics of changes in lactose concentration closely followed the 270 kinetics of milk yield and the inflammatory response, as reflected by significant negative 271 correlations with log SCC and the above-described inflammatory indices, and oxidative-272 stress markers (S1 Fig.) . A significant positive correlation was found between protein 273 level and inflammation parameters, while a significant negative correlation was found 274 between % casein and lactose and inflammation (S1 Fig.) . Regarding clotting parameters, 275 a significant negative correlation was found between CF to inflammation and RCT, and 276 significant positive correlation was found between CF to lactose and % casein (S1 Fig.) , 277 meaning that these parameters were similarly affected by the inflammation process.
278
The pre-challenged Glu concentration was ~289 μM. It increased on day 2 to ~370 279 μM followed by a sharp decrease on day 4 and gradually increase thereafter (Fig. 5 ).
280
Apart from these changes, milk Glu concentration exhibited kinetics that closely followed 281 that of the lactose. Glu6P in milk of the infected glands decreased at first on 12-16 h from 282~49 uM before E. coli inoculation to ~33 μM, increased up to day 4. A sharp increase of 283 Glu6P was observed on 4 DPC, coincidentally to a peak of Glu6P dehydrogenase activity 284 (Glu6PD), decrease of Glu and subsequent peak of Glu6P/Glu ratio at day 4. This peak 285 decreased on 10 DPC and Glu6PD activity gradually returned to pre-challenged levels, 286 as well as Glu6P and the Glu6P/Glu ratio, which then fluctuated until the end of the study 287 ( Fig. 6A, B) .
288
Oxaloacetate levels increased in a two-step way. A first significant increase was 289 observed at ~16 h from ~0.8 mM to ~1.3 mM, then a second sharp increase was measured 290 on 7 DPC to >1.75 mM after which oxaloacetate levels decreased again to ~1.3 mM and 291 remained higher than pre-challenged levels (Fig. 7) . In the infected glands, La and Ma 292 concentrations displayed similar patterns. Their levels started to elevate at ~12 h, peaked 293 on 2-4 DPC and declined thereafter (Fig. 8) . A sharp increase of La was measured earlier, 294 at ~12 h, whereas increase of Ma was detected at 1 DPC. La and Ma levels remained 295 about 6 and 3 folds higher than pre-challenged levels until the end of the experiment, 296 respectively. Pyruvate behaved differently, compared to the previous parameters. 297 Pyruvate levels fluctuated during the first day post-challenge; gradually increasing until 298 a peak > 1400 µM at 7 DPC, after which Pyr levels sharply declined to ~750 µM at 10 299 DPC. By the end of the study, Pyr levels were lower than pre-challenged levels (~600 µM 300 and ~900 µM, respectively) ( Fig. 9 ). Citrate concentration dynamics mirrored that of La 301 and Ma above. Citrate levels sharply decreased at 16 h from 8.9 mM to lowest levels (3.8 302 mM) at 2 DPC, then gradually increased but remained lower on 35 DPC compared to pre-303 challenged levels (Fig. 10) . Consequently, the ratio Cit/La + Ma dropped sharply, starting 304 at 12 h from ~17 to < 1 at 2 DPC and then started to rise to the pre-challenged level ratio 305 at 28 DPC (Fig. 11) . 306 Catalase and lactoperoxidase activity, LDH, BSA and nitrite concentrations 307 displayed similar patterns. Their levels started to elevate at ~12 h PC, peaked at 2-4 DPC 308 and declined to about pre-challenged levels at the end of the study (Fig. 12A-E) . These 309 blood proteins, enzymes and ion significantly positively correlated with SCC and milk 16 310 protein, and significantly negatively correlated with infected glands and cow milk yield, 311 lactose, % casein and CF (S1 Fig.) . Lactoferrin concentration increased in 16-24 h from 312~300 to 1,600 µg/mL, peaked at 7 DPC and declined to the end of the study, but remained 313~ 2 fold higher from the pre-challenge level (Fig. 12F) . IgG concentration increased 314 within 12 h from 0.2 to >2 mg/mL, peaked at 72 DPC > 7, remained in this level up to 21 315 DPC and only then declined, but also remained ~2 fold higher from the pre-challenged 316 level at 35 DPC (Fig. 12G ).
318
Histology at 42 DPC 319 Histological changes in infected and control glands were compared within each and 320 among cows. Overall, the major differences in the control glands was the level of alveolar 321 cuboidal epithelial structure in full lactating glands in the high yielding cows (Fig. 13A) , 322 and increased interlobular collagen rich areas with fibrous stroma and fat in low yielding 323 cows (Fig. 13B) . In challenged glands, regardless if bacteria were isolated on 35 DPC or 324 not, increased interlobular collagen rich areas with fibrous stroma and fat were observed, 325 and in the high yielding cows, normal alveolar structure. Moreover, in most challenged and has been showed in our earlier study [4] . 362 The shift of mammary epithelial cells metabolism to anaerobic glycolysis as a 363 tradeoff between use of Glu to support lactose synthesis and liberation of Glu to support 364 the immune system was thorough fully discussed by Silanikove et al. symptoms, and a chronic phase, independent of bacteria clearance, and in response to the 377 tissue damage caused in the first phase (Fig. 14) . Escherichia coli challenge induces acute conversion of epithelial cells metabolism 422 from principally mitochondrial-oxidative to principally cytosolic (glycolytic), which 423 allows diversion of metabolic resources normally used to synthesize milk and to support 424 the immune system. In turn, reduction in lactose concentration is consistent with the 425 concept that it is part of the defense mechanism of the mammary gland. We suggest a 426 two-phase mechanism for the development of E. coli mastitis. In phase 1, the acute phase, coli. Note the level of alveolar cuboidal epithelial structure in full lactating glands in 550 high yielding cows (Fig. 13A) , and increased interlobular collagen rich fibrous stroma 551 and fat in low yielding cows (Fig. 13B) . In challenged glands, increased interlobular 552 collagen rich areas with fibrous stroma and fat was observed, with mononuclear 553 leucocytes among lobules and PMN within normal alveoli in two out of 10 glands (Fig.   554 13C).
